B. Patel (London, United Kingdom), S. Frent (Timisoara, Romania)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic
F. Mejza (Kraków, Poland), W. Lesniak (Kraków, Poland), R. Jaeschke (Hamilton, Canada)
|   |
Usefulness of the ILD-GAP index in predicting COVID-19 pneumonia prognosis
S. Chakroun (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
| |
IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
N. Acet Öztürk (Bursa, Turkey), A. Ursavas (Bursa, Turkey), A. Görek Dilektasli (Bursa, Turkey), E. Demirdögen (Bursa, Turkey), F. Coskun (Bursa, Turkey), D. Ediger (Bursa, Turkey), E. Uzaslan (Bursa, Turkey), D. Yöyen-Ermis (Bursa, Turkey), M. Karaca (Bursa, Turkey), O. Terzi (Bursa, Turkey), M. Bayram (Bursa, Turkey), D. Ömer (Bursa, Turkey), B. Yigitliler (Bursa, Turkey), A. Yurttas (Bursa, Turkey), S. Maharramov (Bursa, Turkey), G. Çelik (Bursa, Turkey), B. Oral (Bursa, Turkey), M. Karadag (Bursa, Turkey)
| |
The best predictor of COVID-19 pneumonia progression during lung ultrasound (LUS)
K. Bielosludtseva (Dniepropetrovsk, Ukraine), K. Fugol (Dniepropetrovsk, Ukraine), M. Krykhtina (Dniepropetrovsk, Ukraine), O. Popova (Dniepropetrovsk, Ukraine)
| |
Pneumonia severity assessment scores in COVID19 pneumonia; clinical validation in a pragmatic healthcare setting
E. Keramida (Athens, Greece), E. Bellou (Athens, Greece), I. Bracka (Athens, Greece), C. Gkriniouk (Athens, Greece), S. Mazarakis (Athens, Greece), T. Daskalos (Athens, Greece), A. Paraskevas (Athens, Greece), I. Karampinis (Athens, Greece), D. Zorpidou (Athens, Greece), P. Demertzis (Athens, Greece), G. Hardavella (Athens, Greece)
| |
Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts)
D. Koval (Dnipropetrovsk, Ukraine), T. Pertseva (Dnipropetrovsk, Ukraine), L. Konopkina (Dnipropetrovsk, Ukraine), K. Bielosludtseva (Dnipropetrovsk, Ukraine), M. Krykhtina (Dnipropetrovsk, Ukraine)
| |
Fibrinogen like the predictor of COVID-19 pneumonia progression
B. Basina (Dnipropetrovsk, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), T. Kirieieva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine), N. Kravhenko (Dnipro, Ukraine)
| |
The use of double trunk mask to optimize oxygenation in hypoxemic patients with COVID-19: an observational study
A. Zellag (Saint-Etienne, France), I. Court Fortune (Saint-Etienne, France), C. Monneret (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France), E. Botelho-Nevers (Saint-Etienne, France), P. Labeix (Saint-Etienne, France)
| |
Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019
F. Ding (Shanghai, China), Y. Feng (Shanghai, China), L. Han (Shanghai, China), Y. Zhou (Shanghai, China), Y. Ji (Shanghai, China), H. Hao (Shanghai, China), Y. Xue (Shanghai, China), D. Yin (Shanghai, China), Z. Xu (Shanghai, China), S. Luo (Shanghai, China), P. Zhang (Shanghai, China), M. Zhang (Shanghai, China)
| |
Anosmia and ageusia good prognosis factors of COVID-19?
S. Maazaoui (Tunis, Tunisia), a. chaieb (Tunis, Tunisia), S. Habibech (Tunis, Tunisia), T. Zneigui (Tunis, Tunisia), M. Friha (Tunis, Tunisia), S. Ghdira (Tunis, Tunisia), N. Mefteh (Tunis, Tunisia), H. Racil (Tunis, Tunisia), N. Chaouch (Tunis, Tunisia)
| |
Impact of the COVID-19 pandemic on Influenza virus transmission
S. Braga (Guarda, Portugal), M. Oliveira (Guarda, Portugal), J. Silva (Guarda, Portugal), L. Ferreira (Guarda, Portugal)
| |
Willingness for vaccination against COVID19 in health care workers in Greece
D. Papagiannis (Larissa, Greece), G. Rachiotis (Larissa, Greece), F. Malli (Larissa, Greece), G. Perlepe (Larissa, Greece), I. Papathanasiou (Larissa, Greece), E. Fradelos (Larissa, Greece), Z. Daniil (Larissa, Greece), K. Gourgoulianis (Larissa, Greece)
| |
The use of pharmacological therapies in hospitalized COVID-19 patients– A literature review
E. Han (Collegeville, United States of America), E. Lu (Collegeville, United States of America), A. Heyes (Manchester, United Kingdom), J. Mauskopf (North Carolina, United States of America), H. Birch (Brentford, United Kingdom), M. Bracher (Stevanage, United Kingdom), E. Han (Collegeville, United States of America)
| |
Correlation between nasal inflammation and COVID-19 related pneumonia evaluated by nasal cytology.
C. Santomasi (Bari, Italy), A. Portacci (Bari, Italy), F. Barratta (Bari, Italy), P. Pierucci (Bari, Italy), S. Dragonieri (Bari, Italy), M. Gelardi (Foggia, Italy), O. Resta (Bari, Italy), G. Carpagnano (Bari, Italy)
| |
Could KL-6 levels in COVID-19 help to predict lung disease ?
A. Frix (Liege, Belgium), L. Schoneveld (Liege, Belgium), A. Ladang (Liege, Belgium), M. Henket (Liege, Belgium), B. Duysinx (Liege, Belgium), F. Vaillant (Liege, Belgium), B. Misset (Liege, Belgium), M. Moutschen (Liege, Belgium), R. Louis (Liege, Belgium), E. Cavalier (Liege, Belgium), J. Guiot (Liege, Belgium)
| |
Factors associated with poor glycemic control in patients hospitalised for COVID-19
S. Frent (Timisoara, Romania), E. Bobu (Timisoara, Romania), R. Pleava (Kungälv, Sweden), C. Serban (Timisoara, Romania), I. Marincu (Timisoara, Romania), V. Musta (Timisoara, Romania), S. Mihaicuta (Timisoara, Romania), O. Fira-Mladinescu (Timisoara, Romania), D. Manolescu (Timisoara, Romania), C. Oancea (Timisoara, Romania)
| |
COVID-19 Re-infection of Healthcare Workers, A Single Centre Study
M. Ari (Ankara, Turkey), K. Ensarioglu (Ankara, Turkey), S. Duru (Ankara, Turkey), B. Kurt (Ankara, Turkey), I. Sencan (Ankara, Turkey), E. Sendag (Ankara, Turkey)
| |
The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results.
D. Vinokurova (Tomsk, Russian Federation), S. Fedosenko (Tomsk, Russian Federation), E. Kulikov (Tomsk, Russian Federation), S. Nesterovich (Tomsk, Russian Federation), N. Yarovoy (Tomsk, Russian Federation), V. Korepanov (Tomsk, Russian Federation), M. Boldyshevskaya (Tomsk, Russian Federation), S. Khalyavin (Tomsk, Russian Federation), E. Selikhova (Tomsk, Russian Federation)
| |
Differences and characteristics of COVID-19 and atypical pneumonia
M. Turan (Izmir, Turkey), S. Karasu (Izmir, Turkey), A. Cilengir (Izmir, Turkey), B. Sertogullarindan (Izmir, Turkey)
| |